Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Motif Investing is a new way for investors to own a collection of stocks in a certain "motif."
Through the website, an investor can easily identify which trends might be profitable and buy an allotment of pre-selected stocks in that trend, for a low price ($9.99).
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
The site also allows for the selected stocks and weightings in each motif to be changed by the investor.
The top returner (within the biotech space) for the month of January is the "Battling Cancer" motif.
Through January, the motif is up 8 percent, while the S&P 500 ETF is down 1.73 percent.
The motif owns a collection of 25 stocks that are battling cancer in four different sectors: Medical Devices, Mature Biotech, Pharmaceutical and Early Stage Biotech.
The highest-weighted stocks in the portfolio are:
1. Novartis AG (ADR) (NYSE: NVS) at 25 percent
2. Celgene Corporation (NASDAQ: CELG) at 24.1 percent
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
3. Pharmacyclics, Inc. (NASDAQ: PCYC) at 10.6 percent
4. Exact Sciences Corporation (NASDAQ: EXAS) at 4.5 percent
5. Tesaro (NASDAQ: TSRO) at 4.1 percent
The best performers in the portfolio for January are:
1. Foundation Medicine Inc (NASDAQ: FMI) at 109.1 percent
2. Pharmacyclics, Inc. (NASDAQ: PCYC) at 34.9 percent
3. Bind Therapeutics Inc (NASDAQ: BIND) at 29.7 percent
4. Kite Pharma Inc (NASDAQ: KITE) at 28.2 percent
5. Celldex Therapeutics, Inc. (NASDAQ: CLDX) at 22.5 percent
Image credit: Sergey Golyshev, Flickr
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.